The US compression therapy market size is estimated at USD 1.58 billion in 2025 and is estimated to grow by USD 1.63 billion by 2026 to about USD 1.95 billion by 2035 at a CAGR of 2.10% between 2026 and 2035.
US Compression Therapy Market Revenue and Trends
US compression therapy offers compression therapy products such as graduated compression garments, compression wraps, pneumatic compression devices, sequential compression pumps, knee-highs, thigh-highs, pantyhose, sleeves, and bandages in the compression therapy, chronic venous insufficiency, lymphedema, prevention of deep vein thrombosis (DVT), post-surgical edema, varicose veins, diabetic foot, and sports recovery markets.
The US compression therapy market is expanding wonderfully and in a booming way, owing to the escalating cases of venous disorders and obesity, increased orthopedic and vascular surgical operations, aging population, the use of compression based therapies with easy-on/off features, and intermittent pneumatic compression (IPC) systems incorporating digital monitoring in the vascular, wound management, and rehabilitation ecosystems.
.png)
What are the Factors That Have a Significant Contribution to the Growth of the US compression therapy market?
High obesity, sedentary lifestyles, complications of diabetes, and increased life expectancy have led to an increase in the demand for compression therapy products because of the increase in chronic venous disease, lymphedema due to cancer treatment, post-thrombotic syndrome, and lower-extremity edema. With hospital readmissions due to DVT/PE and wound complications continuing to be a significant cost driver, there is increased promotion of compression as a cost-effective, first-line intervention to prevent and control DVT/PE and wound complications (Buck, 2010).
Such developments as Bluetooth-enabled pneumatic compression pumps with compliance-tracking applications, gradient-correct smart stockings with electronic sensors, low-profile athletic compression stockings to aid with sports recovery, antimicrobial silver-impregnated fabrics, and adjustable wraps with Velcro fasteners have been made by technological advancements to benefit patients with limited dexterity, compliance tracking, clinical results, and comfort. Additional influencing factors are the coverage of prescribed compression garments and IPC devices by favorable Medicine and private payers, an increase in physician and wound care center education on compression protocols, an increase in direct-to-consumer channels of athletic and preventive products, strong home health and post-acute care development, and solid clinical evidence on compression in preventing ulcer recurrence and DVT risk.
Segment Insight:
By Product Type
Introduced in the US in the early 1980s as by-products, intermittent pneumatic compression (IPC) devices and sleeves controlled by far the largest portion of the compression therapy market as of 2025, largely due to the strong demand in hospital DVT prophylaxis, postoperative recovery, lymphedema management, and home-use programs, as well as the superior edema reduction methods, compliance monitoring features, and reimbursement support under Medicare Part B, and with further innovation in portable, battery-operated,.
By Distribution Channel
The greatest market presence is between hospitals, outpatient wound care centers, and durable medical equipment (DME) suppliers, and they are the first line vendors of prescription-based compression garments, IPC pumps, and clinical fitting services. These channels have become the choice for acquisition of medical grade compression therapy products since they offer professionalism in limb measurement, custom garment fitting, patient education of donning/doffing, documentation of compliance to facilitate reimbursement, and integration with home health plans.
Report Scope
Feature of the Report | Details |
Market Size in 2026 | USD 1.63 billion |
Projected Market Size in 2035 | USD 1.95 billion |
Market Size in 2025 | USD 1.58 billion |
CAGR Growth Rate | 2.10% CAGR |
Base Year | 2025 |
Forecast Period | 2026-2035 |
Key Segment | By Product Type, Technology, Application, End User, Distribution Channel and Region |
Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Recent Developments
In October 2025: Tactile Medical released the next generation Flexitouch Plus with built-in Bluetooth connectivity and cloud-based compliance reporting, allowing lymphedema patients to be remotely monitored and automated records to be generated to allow Medicare reimbursement in any home health agency and wound care organization in the US.
List of the prominent players in the US Compression Therapy Market:
Cardinal Health Inc.
3M Company
SIGVARIS GROUP
Essity AB
Julius Zorn Inc.
HARTMANN USA Inc.
Bauerfeind USA Inc.
medi USA
BIOCOMPRESSION SYSTEMS
Gottfried Medical Inc.
Tactile Medical
Smith & Nephew
Others
The US Compression Therapy Market is segmented as follows:
By Product Type
Compression Garments
o Compression Stockings
o Compression Sleeves
o Compression Wraps
o Others
Compression Bandages
o Short-Stretch Bandages
o Long-Stretch Bandages
o Multi-Layer Bandage Systems
o Cohesive Bandages
Compression Pumps
o Pneumatic Compression Devices
o Sequential Compression Devices
o Others
Other Products
o Compression Tapes
o Compression Accessories
By Technology
Static Compression Therapy
Dynamic Compression Therapy
Others
By Application
Venous Leg Ulcers
Lymphedema
Deep Vein Thrombosis
Varicose Veins
Post-Surgical Edema
Sports Injuries
Other Applications
By End User
Hospitals and Clinics
Home Healthcare
Nursing Care Centers
Sports and Fitness Centers
Other End Users
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Specialty Stores
